These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1167 related items for PubMed ID: 30122568

  • 1. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T, Panichyawat N, Indhavivadhana S, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Pratumvinit B, Sa-Nga-Areekul N.
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [Abstract] [Full Text] [Related]

  • 2. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 3. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME, Jarrett BY, Brooks ED, Reines JK, Peppin AK, Muhn N, Haider E, Pierson RA, Chizen DR.
    Hum Reprod; 2013 May 01; 28(5):1361-8. PubMed ID: 23503943
    [Abstract] [Full Text] [Related]

  • 4. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
    Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, Escobar-Morreale HF.
    Hum Reprod Update; 2014 May 01; 20(3):334-52. PubMed ID: 24345633
    [Abstract] [Full Text] [Related]

  • 5. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D, Alebić MŠ, Duhamel A, Stojanović N.
    Hum Reprod; 2014 Nov 01; 29(11):2536-43. PubMed ID: 25267785
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.
    Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P, Duhamel A, Catteau-Jonard S.
    Hum Reprod; 2011 Nov 01; 26(11):3123-9. PubMed ID: 21926054
    [Abstract] [Full Text] [Related]

  • 7. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.
    Acta Obstet Gynecol Scand; 2013 Dec 01; 92(12):1369-74. PubMed ID: 23980726
    [Abstract] [Full Text] [Related]

  • 8. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.
    Hum Reprod; 2014 Apr 01; 29(4):791-801. PubMed ID: 24435776
    [Abstract] [Full Text] [Related]

  • 9. AMH MEASUREMENT VERSUS OVARIAN ULTRASOUND IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME IN DIFFERENT PHENOTYPES.
    Carmina E, Campagna AM, Fruzzetti F, Lobo RA.
    Endocr Pract; 2016 Mar 01; 22(3):287-93. PubMed ID: 26523627
    [Abstract] [Full Text] [Related]

  • 10. Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome.
    Matsuzaki T, Munkhzaya M, Iwasa T, Tungalagsuvd A, Yano K, Mayila Y, Yanagihara R, Tokui T, Kato T, Kuwahara A, Matsui S, Irahara M.
    Endocr J; 2017 May 30; 64(5):531-541. PubMed ID: 28381699
    [Abstract] [Full Text] [Related]

  • 11. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S, Ruan J, Huang W, Tan J, Zhang X, Feng X, Liu D, Fu J, Zhou L, Zhou M.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov 30; 50(11):819-24. PubMed ID: 26887768
    [Abstract] [Full Text] [Related]

  • 12. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ, Stojanović N, Duhamel A, Dewailly D.
    Hum Reprod; 2015 Aug 30; 30(8):1927-33. PubMed ID: 26048913
    [Abstract] [Full Text] [Related]

  • 13. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Łebkowska A, Adamska A, Karczewska-Kupczewska M, Nikołajuk A, Otziomek E, Milewski R, Górska M, Wołczyński S, Kowalska I.
    Metabolism; 2016 May 30; 65(5):804-811. PubMed ID: 26961579
    [Abstract] [Full Text] [Related]

  • 14. The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome.
    Casadei L, Madrigale A, Puca F, Manicuti C, Emidi E, Piccione E, Dewailly D.
    Gynecol Endocrinol; 2013 Jun 30; 29(6):545-50. PubMed ID: 23506275
    [Abstract] [Full Text] [Related]

  • 15. Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis.
    Pea J, Bryan J, Wan C, Oldfield AL, Ganga K, Carter FE, Johnson LM, Lujan ME.
    Hum Reprod Update; 2024 Jan 03; 30(1):109-130. PubMed ID: 37804097
    [Abstract] [Full Text] [Related]

  • 16. Follicle number, not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome.
    Christ JP, Willis AD, Brooks ED, Vanden Brink H, Jarrett BY, Pierson RA, Chizen DR, Lujan ME.
    Fertil Steril; 2014 Jan 03; 101(1):280-287.e1. PubMed ID: 24188871
    [Abstract] [Full Text] [Related]

  • 17. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.
    Pigny P, Jonard S, Robert Y, Dewailly D.
    J Clin Endocrinol Metab; 2006 Mar 03; 91(3):941-5. PubMed ID: 16368745
    [Abstract] [Full Text] [Related]

  • 18. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1716-1722. PubMed ID: 28854589
    [Abstract] [Full Text] [Related]

  • 19. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H, Hellström M, Gull B, Lind AK, Nilsson L, Janson PO, Stener-Victorin E.
    Fertil Steril; 2014 Jun 01; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [Abstract] [Full Text] [Related]

  • 20. Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS.
    Rudnicka E, Kunicki M, Calik-Ksepka A, Suchta K, Duszewska A, Smolarczyk K, Smolarczyk R.
    Int J Mol Sci; 2021 Nov 19; 22(22):. PubMed ID: 34830389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.